Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2082)	10/3/1997 10:56:00 PM
From: Bhag Karamchandani	of 6136

One of the abstracts posted from the recent Toronto Conference mentioned indications of increased immunity in AIDS patients who successfully adhere to the prescribed regimen of ' combo cocktail'. Can any one provide additional information on this? Another point : we can not forget that the limitations of the PI treatment pale, in relation to the unacceptable alternative resulting from non treatment. May be the next generation of drugs will address the resistance problem. No one suggests the discontinuance of insulin, because it has been known for the last fifty years, that it does not cure diabetes. In other words, inadequate treatments must unfortunately be accepted, in the absence of a cure. Also, the percentage of AIDS patients in anti viral teatment program is less than 1/3 of the total population of AIDS sufferrers in the US. Even the current recommended treatment is not being accessed by all. The situation has to be much worse outside US. Regrettably, the discussion about limitations of current PI based treatments at this point, in the absence any other approved treatment, may be academic.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next